- Filed
- May 20, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 19, 2025 | 92.21M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 92.21M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 26.63M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | $46K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$1.9M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $77K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $84K |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$34.3M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$33.16M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$47.13M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$43.8M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $35M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $34.45M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $35.69M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $35.3M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.74M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.38M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.14M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | $0.00 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.17 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.17 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $352K |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $1.23M |
| Net Income | Q1 2025 · Mar 31, 2025 | −$229K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$4.52M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$198K |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$1.28M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $323K |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $175K |
| Revenue | Q1 2025 · Mar 31, 2025 | $477K |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $127K |